Recombinant COVID-19 Vaccine (CHO Cell)
COVID-19 Prevention
Key Facts
Indication
COVID-19 Prevention
Phase
Marketed
Status
Approved (Conditional)
Company
About Zhifei Biological Products
Zhifei Biological Products is a Chinese biopharmaceutical leader with a mission to 'guard life and convey health.' The company has achieved significant scale through its successful 'technology & market' dual-drive model, combining a robust proprietary R&D engine with an unparalleled domestic commercialization network. Its strategic includes exclusive partnerships with global giants like Merck and GSK, a deep pipeline across nine technology platforms, and expansion into broader therapeutic areas including metabolic and autoimmune diseases.
View full company profileOther COVID-19 Prevention Drugs
| Drug | Company | Phase |
|---|---|---|
| Intranasal COVID Vaccine | Virpax Pharmaceuticals | Research |
| COVID-19 Vaccine Trials | DM Clinical Research | Not Specified |
| SARS-CoV-2 Vaccine | Epygen Biotech | Not Disclosed |
| IRT Platform (e.g., COVID-19) | Biological Mimetics | Research/Pre-clinical |
| COMIRNATY® (BNT162b2) | Fosun Pharma | Approved |
| BBIBP-CorV | Sinopharm | Approved |
| Recombinant Protein COVID-19 Vaccine | Sinopharm | Approved |
| COVID-19 mRNA Vaccine (SYS6006) | CSPC Innovation Pharmaceutical | Marketed |
| SARS-CoV-2 Inactivated Vaccine | Hualan Biological Engineering | Marketed |
| CoronaVac | Sinovac Biotech | Approved |